Mirum Pharmaceuticals, Inc. MIRM Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Mirum Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s interest coverage?
- Mirum Pharmaceuticals, Inc. (MIRM) reported interest coverage of -55.3× in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s interest coverage changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s interest coverage decreased by 937.8% year-over-year, from -5.3× to -55.3×.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s interest coverage?
- Over 3 years (2022 to 2025), Mirum Pharmaceuticals, Inc.'s interest coverage has grown at a -42.8% compound annual growth rate (CAGR), from -8.2× to -1.5×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.